Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and ...
Berry Genomics plans to expand its sequencing capability to clinical assays like congenital adrenal hyperplasia and spinal muscular atrophy.
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
Focused power on the MiSeq i100 System Access focused applications such as targeted resequencing, metagenomics, small genome sequencing, targeted gene expression profiling, and more. MiSeq i100 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback